The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

NCT01634321 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Precocious Puberty

Interventions

DRUG: Luphere depot 3.75mg(Leuprolide acetate 3.75mg)

Sponsor

Daewoong Pharmaceutical Co. LTD.